Boule Diagnostics

Boule is a diagnostic company that develops, manufactures and sells systems and consumer products for hematology to non-institutional healthcare. Sales are carried out through a world wide network of distributors, covering more than 100 countries. The company focuses primarily on small and midsize hospitals, clinics and laboratories in non-institutional healthcare, as well as other diagnostic companies in both human and veterinary hematology. Operations are conducted through commercial subsidiaries in Sweden, the US and China. The business was founded in 1992 with the acquisition of Karo Bio Diagnostics AB. But the company’s history goes back to the 1950′s when the founder of Swelab Instrument AB, Erik Öhlin, developed Europe’s first automatic blood cell counter. This is an early predecessor of today’s instruments from Boule. The founders of Boule’s American subsidiary, Clinical Diagnostic Solutions Inc., (CDS) has a similar history from Coulter Corporation which developed the world’s first blood cell counter.

Kiarash Farr

Senior Vice President, Commercial Operations

Hans Johansson

Senior Vice President of Production

Christina Rubenhag

CFO

Jesper Söderqvist

CEO and Group President

Erik Öhlin

Founder

1 past transactions

Biosurfit

Series A in 2018
At biosurfit they are working to shape the future of in-vitro diagnostic testing. They want health providers to have all the necessary information to make the best possible diagnostic and treatment decision when they are with their patients
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.